Michael Byrnes
2022 - eFFECTOR Therapeutics
In 2022, Michael Byrnes earned a total compensation of $2M as Chief Financial Officer at eFFECTOR Therapeutics, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,865 |
|---|---|
| Option Awards | $1,351,611 |
| Salary | $435,735 |
| Other | $31,090 |
| Total | $1,975,301 |
Byrnes received $1.4M in option awards, accounting for 68% of the total pay in 2022.
Byrnes also received $156.9K in non-equity incentive plan, $435.7K in salary and $31.1K in other compensation.
Rankings
In 2022, Michael Byrnes' compensation ranked 1,756th out of 5,625 executives tracked by ExecPay. In other words, Byrnes earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,756 out of 5,625 | 69th |
Division Manufacturing | 919 out of 3,053 | 70th |
Major group Chemicals And Allied Products | 368 out of 1,380 | 73rd |
Industry group Drugs | 336 out of 1,281 | 74th |
Industry Pharmaceutical Preparations | 242 out of 927 | 74th |
Source: SEC filing on May 12, 2023.
Byrnes' colleagues
We found four more compensation records of executives who worked with Michael Byrnes at eFFECTOR Therapeutics in 2022.